Profile
ELUT VRTX REGN VRNA ARGX ALNY
Company Name Elutia Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $42.15M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.05K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO C. Randal Mills Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ELUT VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ELUT VRTX REGN VRNA ARGX ALNY
Last Close $0.7303 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $4.84 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.73 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -84.91 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 0.04 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ELUT VRTX REGN VRNA ARGX ALNY
1 Month Return -18.01 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -63.85 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -57.54 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -74.47 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -80.47 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -82.65 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ELUT VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -60.42 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ELUT VRTX REGN VRNA ARGX ALNY
Asset Growth -16.81 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -3.13 % 1.16 % - 26.81 %
Revenue Growth -1.5 % 0.99 % - 22.97 %
Revenue 3 Year -81.52 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year -79.15 % 73.64 % - 775.72 %
Revenue 10 Year -77.09 % 285.02 % - 2487.4 %
EBIT Growth -39.29 % 9.09 % -131.37 % 24.59 %
Net Income Growth -43.27 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 21.94 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -65.81 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -71.15 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -16.79 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -4.12 % - -143.33 % -107.98 %
Operating 3 Year CFG 47.3 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -15.07 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -62.22 % -100 % 40.15 % 97.08 %
EPS Growth 10.14 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 10.14 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 25.13 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -222.92 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 69.2 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 60.89 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 3.27 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -5.45 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ELUT VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 45.97 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -90.02 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 62.85 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 263.58 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 115.29 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 73.04 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -149.1 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -111.55 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 5.93 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.82 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 5.66 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 456.46 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 71.7 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.72 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.73 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 11.52 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -139.28 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.65 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -111.55 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -1.41 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -1.38 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -1.38 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
ELUT VRTX REGN VRNA ARGX ALNY
Revenue $0.02B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0.01B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 43.93% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.05B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.05B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.86 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ELUT VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.02B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.08B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $-0.05B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0.02B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.04B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ELUT VRTX REGN VRNA ARGX ALNY
Net Income $-0.05B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $-0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.6
AARD Aardvark Therapeutics, Inc. Common Stock 12.67
ABCL AbCellera Biologics Inc. 3.135
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.06
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.56
ABPWW 0.0133
ABSI Absci Corporation 2.6
ABUS Arbutus Biopharma Corporation 4.16
ABVC ABVC BioPharma, Inc. 1.73
ABVX Abivax SA American Depositary Shares 122.77
ACAD ACADIA Pharmaceuticals Inc. 22.47
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.81
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.28
ACIU AC Immune SA 3.03
ETFs With Exposure to ELUT
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 341.47
VXF Vanguard Extended Market Index Fund 0.0002 218.1
IWC iShares Micro-Cap ETF 0.01 168.25
VUN.TO Vanguard U.S. Total Market Index ETF 0.00003 126.01
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00003 118.61
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00009 52.53
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00009 52.52
VBINX Vanguard Balanced Index Fund Investor Shares 0.00009 52.53
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.38
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.86
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.88
VCNS.TO Vanguard Conservative ETF Portfolio 0 32.13
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.34
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.99
VTSAX Vanguard Total Stock Market Index Fund 0.00003 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.0002 165.55
VITSX Vanguard Total Stock Market Index Fund 0.00003 166.27
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.0002 165.56
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 481.52
VEMPX Vanguard Extended Market Index InstlPlus 0.0002 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 311.9
Unlock